Potassium iodide and the Wolff-Chaikoff effect: Relevance for the dermatologist

Journal of the American Academy of Dermatology

Volumn 42, Issue 3, 2000, Pages 490-492

  Heymann, Warren R ^a,b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM IODIDE;

ARTICLE; CLINICAL FEATURE; DRUG INDICATION; DRUG RESPONSE; HUMAN; HYPOTHYROIDISM; IODINATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SKIN INFLAMMATION; THYROID FUNCTION;

EID: 0033911316     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(00)90224-X     Document Type: Article

References (23)

1. Horio T, Danno K, Okamoto H, Miyachi Y, Imamura S. Potassium iodide in erythema nodosum and other erythematous dermatoses. J Am Acad Dermatol 1983;9:77-81.
2. Cabezas C, Bustamante B, Holgado W, Begue RE. Treatment of cutaneous sporotrichosis with one daily dose of potassium iodide. Pediatr Infect Dis J 1996;15:352-4.
3. Lesher JL Jr, Fitch MH, Dunlap DB. Subclinical hypothyroidism during potassium iodide therapy for lymphocutaneous sporotrichosis. Cutis 1994;53:128-30.
4. Gerding DN. Treatment of pulmonary sporotrichosis. Semin Respir Infect 1986;1:61-5.
5. Kauffman CA. Old and new therapies for sporotrichosis. Clin Infect Dis 1995;21:981-5.
6. Schulz EJ, Whiting DA. Treatment of erythema nodosum and nodular vasculitis with potassium iodide. Br J Dermatol 1976; 94:75-8.
7. Horio T, Imamura S, Danno K, Ofuji S. Potassium iodide in the treatment of erythema nodosum and nodular vasculitis. Arch Dermatol 1981;117:29-31.
8. Rostas A, Lowe D, Smout MS. Erythema nodosum migrans in a young woman. Arch Dermatol 1980;116:325-6.
9. Woeber KA. Iodine and thyroid disease. Med Clin North Am 1991;75:169-78.
10. Honma K, Saga K, Onodera H, Takahashi M. Potassium iodide inhibits neutrophil chemotaxis. Acta Derm Venereol (Stockh) 1990;70:247-9.
11. Wilkin JK, Strobel D. Iododerma occurring during thyroid protection treatment. Cutis 1985;36:335-7.
12. Halperin JA. Potassium iodide as a thyroid blocker - Three Mile Island to today. DICP 1989;23:422-7.
13. Heidemann PH, Stubbe P, Schurnbrand P, Prindull G. Iodine-induced hypothyroidism and goiter following lipiodol lymphography. Eur J Pediatr 1982;138:82-3.
14. Harjai KJ, Licata AA. Effects of amiodarone on thyroid function. Ann Intern Med 1997;126:63-73.
15. DeGroot LJ, Larsen PR, Hennemann G. Thyroid hormone synthesis and secretion. In: DeGroot LJ, Larsen PR, Hennemann G, editors. The thyroid and its diseases. New York: Churchill Livingstone; 1996. p. 33-60.
16. Heymann WR. Cutaneous manifestations of thyroid disease. J Am Acad Dermatol 1992;26:885-902.
17. Wartofsky L. Diseases of the thyroid. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, et al, editors. Harrison's Principles of internal medicine. 14th ed. New York: McGraw-Hill; 1998. p. 2012-35.
18. Chiraseveenuprapund P, Rosenberg IN. Effects of hydrogen peroxide-penetrating systems on the Wolff-Chaikoff effect. Endocrinology 1981;109:2095-102.
19. Roti E, Minelli R, Gardini E, Bianconi L, Braverman LE. Iodine-induced hypothyroidism in euthyroid subjects with a previous episode of subacute thyroiditis. J Clin Endocrinol Metab 1990; 70:1581-5.
20. Roti E, Minelli R, Gardini E, Bianconi L, Gavaruzzi G, Ugliotti G, et al. Iodine-induced subclinical hypothyroidism in euthyroid subjects with a previous episode of amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 1992;75:1273-7.
21. Yamamoto K, DeGroot LJ. Function of peroxidase and NADPH cytochrome c reductase during the Wolff-Chaikoff effect. Endocrinol 1973;93:822-8.
22. Corvilain B, Laurent E, Lecompte M, Vansande J, Dumont JE. Role of the cyclic adenosine 3′,5′-monophosphate and the phosphatidylinositol-Ca2+ cascades in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices. J Clin Endocrinol Metab 1994;79:152-9.
23. Jubiz W, Carlile S, Laperquist LD. Serum thyrotropin and thyroid hormone levels in humans receiving chronic potassium iodide. J Clin Endocrinol Metab 1977;44:379-82.